Ranitidine Injection 50mg/2ml is a sterile solution designed for intravenous or intramuscular administration, providing effective inhibition of gastric acid secretion. Formulated according to the British Pharmacopoeia (BP) standards, this H2 blocker is utilized primarily in hospital settings and clinical environments to treat conditions such as peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Each 2ml ampoule contains 50mg of ranitidine, ensuring precise dosing and rapid onset of action. The injection comes in a tray pack of 10 ampoules, facilitating easy storage and handling in healthcare institutions. This formulation is especially critical for patients who cannot tolerate oral medication and require swift acid suppression through parenteral routes, making it a vital component in emergency and inpatient care for acid-related gastrointestinal disorders.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Ranitidine Hydrochloride 50mg |
| Dosage Form | Injection (Sterile Solution) |
| Concentration | 50mg per 2ml Ampoule |
| Pharmacopeia Standard | British Pharmacopoeia (BP) Certified |
| Therapeutic Category | H2 Receptor Blocker |
| Pack Type | Ampoule |
| Pack Size | Tray Pack of 10 Ampoules |
| Route of Administration | Intravenous or Intramuscular |
| Sterility | Sterile Injection Solution |
| Intended Usage | Treatment of Gastric Hyperacidity and Related Disorders |
| Attributes | Description |
|---|---|
| Active Ingredient | Ranitidine Hydrochloride |
| Strength | 50mg/2ml |
| Dosage Form | Injection (Solution) |
| Pharmacopeia Compliance | British Pharmacopoeia (BP) |
| Therapeutic Class | H2 Blockers |
| Packaging | Tray pack of 10 ampoules |
| Ampoule Volume | 2ml |
| Administration Route | IV/IM Injection |
| Sterility | Sterile |
| Storage Condition | Store below 25°C, protect from light |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Yes, the Ranitidine Injection 50mg/2ml is manufactured in compliance with the British Pharmacopoeia (BP) standards ensuring quality and safety.
This injection is intended for intravenous (IV) or intramuscular (IM) administration as per clinical guidelines.
It is supplied as a tray pack containing 10 sterile 2ml ampoules, facilitating ease of use and storage in healthcare settings.
It is primarily used for treating conditions associated with excessive gastric acid secretion, such as ulcers and GERD, especially when oral medication is not feasible.
The injection should be stored below 25°C and protected from direct light to preserve its potency.
Country Of Origin: India
Ranitidine Injection is a biocompatible injectable formulation for targeted H2 receptor antagonism, facilitating gastric acid suppression in acute clinical applications.
The 50mg/2ml volume provides a standardized dose, enabling precise administration and predictable therapeutic efficacy.
Ranitidine Injection contains pharmaceutically pure Ranitidine Hydrochloride in sterile isotonic aqueous medium. Buffering agents maintain pH stability and prevent degradation, while excipients ensure solubility and homogeneity for reliable parenteral administration.
The injection provides consistent bioavailability and rapid onset of action. Its optimized viscosity facilitates smooth intravenous or intramuscular administration with minimal discomfort. Stability under ambient and refrigerated conditions ensures predictable pharmacodynamics for professional clinical use.
Ranitidine Injection is widely used in hospital pharmacies, emergency care units, and institutional procurement channels. Its bulk sourcing, OEM supply, and export-ready packaging align with regulated pharmaceutical markets, supporting professional B2B buyers seeking reliable acid-suppressive injectable therapy.
